Disclosed herein is an infection protectant which is excellent in infection protective effects and is also safe. .kappa.-Casein, a sialic-acid-conjugated protein derived from cow milk, and a glycomacropeptide derived from .kappa.-casein, each of which is useful as an active ingredient in this invention, have been found to be effective for the prevention of adhesion of E. coli on cells and also for the inhibition of transformation of lymphocytes by EBV and also to have strong HI activity against ...

An orally ingestible anti-tapeworm infection composition for mammals which comprises a therapeutically effective non-toxic amount of a compound selected from the class consisting of a base of Formula (I) wherein R is alkyl having from three to eight carbon atoms, R' is alkyl having from one to 11 carbon atoms, wherein both the Rs attached to the nitrogen atom are the same, and in which the sum of the carbons in Rs and R' is 12 to 19, and a pharmaceutically acceptable acid addition salt of said b...

Disclosed herein is an infection protectant which is excellent in infection protective effects and is also safe. .kappa.-Casein, a sialic-acid-conjugated protein derived from cow milk, and a glycomacropeptide derived from .kappa.-casein, each of which is useful as an active ingredient in this invention, have been found to be effective for the prevention of adhesion of E. coli on cells and also for the inhibition of transformation of lymphocytes by EBV and also to have strong HI activity against ...

The administration internally to humans of 1-(.beta.-hydroxethyl)-2-methyl-5-nitromidazole, (metronidazole) in a dosage range for adult humans of about 31 to 1,000 mgs per twenty-four hour period, is an effective therapeutic treatment certain of viral infections.

A method and associated agents for the arrest of infections resulting from organism growth in contact with an iron-containing body fluid, comprising administering an agent capable of immobilizing the body fluid so that the iron it contains is nutritionally unavailable for the organism. In the instance where the body fluid is blood, the agent may be administered in amounts effective to bind all of the available red blood cells or hemoglobin, to prevent breakdown of either and consequent release o...

A method for the selective treatment of virus infections in animals and man and a method of treating cancer caused by viruses, comprising administering to a host so infected a therapeutically effective amount of phosphonoformic acid or a physiologically acceptable salt thereof.

A method for arresting fulminating infections of traumatized animal tissue comprises administering to the locus of the tissue trauma an agent capable of binding iron made available to infection-promoting organisms by body fluid released by the trauma. The agent is administered in an amount sufficient to bind all of the available iron, to thereby block the adsorption of the iron by the infection-promoting organisms. The agent preferably comprises one or more binding proteins having known specific...

Treatment of AIDS or humans carrying or infected with the AIDS virus or having antibodies to the AIDS virus is disclosed using the compound 3'-azido-3'-deoxythymidine or a pharmaceutically acceptable basic salt thereof. Also disclosed is the use of 5'-mono-, di- and triphosphate of 3'-azido-3'-deoxythymidine or a pharmaceutically acceptable basic salt thereof for the same purpose.

A method for the selective treatment of virus infections in animals and man comprising administering to a host so infected a therapeutically effective amount of phosphonoformic acid or a physiologically acceptable salt thereof.

Method of treating retrovirus infection by administering extract of Phyllanthus niruri.